Interwest Venture Management

Latest statistics and disclosures from Interwest Venture Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PMVP, REAL, SERA, GKOS, Dare Bioscience, and represent 100.00% of Interwest Venture Management's stock portfolio.
  • Interwest Venture Management has $21M in assets under management (AUM), dropping by -15.83%.
  • Central Index Key (CIK): 0001697720

Tip: Access up to 7 years of quarterly data

Positions held by Interwest Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Interwest Venture Management

Interwest Venture Management holds 5 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pmv Pharmaceuticals (PMVP) 48.1 $9.9M 1.6M 6.14
 View chart
Realreal (REAL) 24.1 $5.0M 2.4M 2.11
 View chart
Sera Prognostics Class A Com (SERA) 21.8 $4.5M 2.4M 1.86
 View chart
Glaukos (GKOS) 6.0 $1.2M 16k 75.25
 View chart
Dare Bioscience 0.1 $29k 62k 0.46
 View chart

Past Filings by Interwest Venture Management

SEC 13F filings are viewable for Interwest Venture Management going back to 2016

View all past filings